Developing a preclinical model of Parkinson's disease: A study of behaviour in rats with graded 6-OHDA lesions

Behavioural Brain Research

Volumn 169, Issue 1, 2006, Pages 1-9

  Truong, L ^a   Allbutt, H ^a   Kassiou, M ^a,b   Henderson, J M ^a  

^a University of Sydney   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

6 Hydroxydopamine; Parkinsonism; Partial lesion; Preclinical model; Rotation; Tyrosine hydroxylase

Indexed keywords

APOMORPHINE; OXIDOPAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BODY EQUILIBRIUM; BODY POSTURE; CELL LOSS; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DOPAMINERGIC NERVE CELL; FEMALE; FOREBRAIN; IMMUNOCOMPETENT CELL; LOCOMOTION; MOTOR DYSFUNCTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SENSORIMOTOR FUNCTION; SENSORY DYSFUNCTION; STATISTICAL SIGNIFICANCE; SUBSTANTIA NIGRA; SYMPTOMATOLOGY;

ANALYSIS OF VARIANCE; ANIMALS; CELL DEATH; DIAGNOSIS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FUNCTIONAL LATERALITY; MEDIAL FOREBRAIN BUNDLE; MICROINJECTIONS; MOTOR ACTIVITY; NEURAL PATHWAYS; NEURONS; OXIDOPAMINE; PARKINSONIAN DISORDERS; PROPRIOCEPTION; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 33244457440     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2005.11.026     Document Type: Article

References (44)

1. L.E. Annett, D.C. Rogers, T.D. Hernandez, and S.B. Dunnett Behavioural analysis of unilateral monoamine depletion in the marmoset Brain 115 1992 825 856
2. P. Barneoud, E. Descombris, N. Aubin, and D.N. Abrous Evaluation of simple and complex sensorimotor behaviours in rats with a partial lesion of the dopaminergic nigrostriatal system Eur J Neurosci 12 2000 322 336
3. P. Barneoud, S. Parmentier, M. Mazadier, J.M. Miquet, A. Boireau, and P. Dubedat Effects of complete and partial lesions of the dopaminergic mesotelencephalic system on skilled forelimb use in the rat Neuroscience 67 1995 837 848
4. K. Berger, S. Przedborski, and J.L. Cadet Retrograde degeneration of nigrostriatal neurons induced by intrastriatal 6-hydroxydopamine injection in rats Brain Res Bull 26 1991 301 307
5. H. Bergman, T. Wichmann, and B. Karmon DeLong MR. the primate subthalamic nucleus II. Neuronal activity in the MPTP model of parkinsonism J Neurophysiol 72 1994 507 520
6. C.V. Borlongan, and P.R. Sanberg Elevated body swing test: a new behavioral parameter for rats with 6-hydroxydopamine-induced hemiparkinsonism J Neurosci 15 1995 5372 5378
7. L.S. Carman, F.H. Gage, and C.W. Shults Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior Brain Res 553 1991 275 283
8. M. Casas, S. Ferre, A. Cobos, J. Cadafalch, J.M. Grau, and F. Jane Comparison between apomorphine and amphetamine-induced rotational behaviour in rats with a unilateral nigrostriatal pathway lesion Neuropharmacol 27 1988 657 659
9. T.J. Collier, K. Steece-Collier, and J.H. Kordower Primate models of Parkinson's disease Exp Neurol 183 2003 258 262
10. A.R. Crossman A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: implications for future strategies in treatment Mov Disord 5 1990 100 108
11. R. Deumens, A. Blokland, and J. Prickaerts Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway Exp Neurol 175 2002 303 317
12. E. Emborg Evaluation of animal models of Parkinson's disease for neuroprotective strategies J Neurosci Meth 131 2004 121 143
13. A. Eslamboli, H.F. Baker, R.M. Ridley, and L.E. Annett Sensorimotor deficits in a unilateral intrastriatal 6-OHDA partial lesion model of Parkinson's disease in marmoset monkeys Exp Neurol 183 2003 418 429
14. E.V. Evarts, H. Teravainen, and D.B. Calne Reaction time in Parkinson's disease Brain 104 1981 167 186
15. J.M. Fearnley, and A.J. Lees Ageing and Parkinson's disease: substantia nigra regional selectivity Brain 114 1991 2283 2301
16. M. Gerlach, K. Double, H. Reichmann, and P. Riederer Arguments for the use of dopamine receptor agonists in clinical and preclinical Parkinson's disease J Neural Transm 65 2003 167 183
17. W.R. Gibb Functional neuropathology in Parkinson's disease Eur Neurol 38 1997 21 25
18. F. Hefti, E. Melamed, B.J. Sahakian, and R.J. Wurtman Circling behavior in rats with partial, unilateral nigro-striatal lesions: effect of amphetamine, apomorphine, and DOPA Pharmacol Biochem Behav 12 1980 185 188
19. J.M. Henderson, and S.B. Dunnett Targeting the subthalamic nucleus in the treatment of Parkinson's disease Brain Res Bull 46 1998 467 474
20. J.M. Henderson, S. Watson, G.M. Halliday, T. Heinemann, and M. Gerlach Relationships between various behavioural abnormalities and nigrostriatal dopamine depletion in the unilateral 6-OHDA-lesioned rat Behav Brain Res 139 2003 105 113
21. J.M. Henderson, and S.H. Watson Convulsive and postural effects of lesioning the mid-substantia nigra pars reticulata in naive and 6-hydroxydopamine lesioned rats Brain Res Bull 60 2003 179 185
22. M.M. Hoehn, and M.D. Yahr Parkinsonism: onset, progression and mortality Neurology 17 1967 427 442
23. J.L. Hudson, C.G. van Horne, I. Stromberg, S. Brock, J. Clayton, and J. Masserano Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats Brain Res 626 1993 167 174
24. Y. Ichitani, H. Okamura, Y. Matsumoto, I. Nagatsu, and Y. Ibata Degeneration of the nigral dopamine neurons after 6-hydroxydopamine injection into the rat striatum Brain Res 549 1991 350 353
25. D. Kirik, C. Rosenblad, and A. Bjorklund Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat Exp Neurol 152 1998 259 277
26. W.C. Koller, and M.G. Cersosimo Neuroprotection in Parkinson's disease: an elusive goal Curr Neurol Neurosci Rep 4 2004 277 283
27. P. Lamberti, S. Armenise, V. Castaldo, M. de Mari, G. Iliceto, and P. Tronci Freezing gait in Parkinson's disease Eur Neurol 38 1997 297 301
28. E. Melamed, F. Hefti, and R.J. Wurtman Compensatory mechanisms in the nigrostriatal dopaminergic system in Parkinson's disease: studies in an animal model Isr J Med Sci 18 1982 159 163
29. Movement Disorder Society Task Force on Rating Scales for Parkinson's, D. (2003). The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations. Mov Disord. 2003;18:738-50.
30. Y. Oiwa, R. Sanchez-Pernaute, J. Harvey-White, and K.S. Bankiewicz Progressive and extensive dopaminergic degeneration induced by convection-enhanced delivery of 6-hydroxydopamine into the rat striatum: a novel rodent model of Parkinson disease J Neurosurg 98 2003 136 144
31. G. Orieux, C. Francois, J. Feger, J. Yelnik, M. Vila, and M. Ruberg Metabolic activity of excitatory parafascicular and pedunculopontine inputs to the subthalamic nucleus in a rat model of Parkinson's disease Neuroscience 97 2000 79 88
32. K. Ossowska, J. Wardas, M. Smialowska, K. Kuter, T. Lenda, and J.M. Wieronska A slowly developing dysfunction of dopaminergic nigrostriatal neurons induced by long-term paraquat administration in rats: an animal model of preclinical stages of Parkinson's disease? Eur J Neurosci 22 2005 1294 1304
33. S. O'Shea, M.E. Morris, and R. Iansek Dual task interference during gait in people with Parkinson disease: effects of motor versus cognitive secondary tasks Phys Ther 82 2002 888 897
34. S. Przedborski, M. Levivier, H. Jiang, M. Ferreira, V. Jackson-Lewis, and D. Donaldson Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine Neuroscience 67 1995 631 647
35. M. Rodriguez Diaz, P. Abdala, P. Barroso-Chinea, J. Obeso, and T. Gonzalez-Hernandez Motor behavioural changes after intracerebroventricular injection of 6-hydroxydopamine in the rat: an animal model of Parkinson's disease Behav Brain Res 122 2001 79 92
36. M. Rodriguez, P. Barroso-Chinea, P. Abdala, J. Obeso, and T. Gonzalez-Hernandez Dopamine cell degeneration induced by intraventricular administration of 6-hydroxydopamine in the rat: similarities with cell loss in parkinson's disease Exp Neurol 169 2001 163 181
37. H. Sauer, and W.H. Oertel Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat Neuroscience 59 1994 401 415
38. N. Sawamoto, M. Honda, T. Hanakawa, H. Fukuyama, and H. Shibasaki Cognitive slowing in Parkinson's disease: a behavioral evaluation independent of motor slowing J Neurosci 22 2002 5198 5203
39. M.A. Silverdale, S.H. Fox, A.R. Crossman, and J.M. Brotchie Potential nondopaminergic drugs for Parkinson's disease Adv Neurol 91 2003 273 291
40. D.D. Song, and S.N. Haber Striatal responses to partial dopaminergic lesion: evidence for compensatory sprouting J Neurosci 20 2000 5102 5114
41. D. Stanic, D.I. Finkelstein, D.W. Bourke, J. Drago, and M.K. Horne Timecourse of striatal re-innervation following lesions of dopaminergic SNpc neurons of the rat Eur J Neurosci 18 2003 1175 1188
42. U. Ungerstedt, T. Ljungberg, and G. Steg Behavioral, physiological, and neurochemical changes after 6-hydroxydopamine-induced degeneration of the nigro-striatal dopamine neurons Adv Neurol 5 1974 421 426
43. P. Vieregge, H. Stolze, C. Klein, and I. Heberlein Gait quantitation in Parkinson's disease - locomotor disability and correlation to clinical rating scales J Neural Transm 104 1997 237 248
44. M.J. Zigmond, A.L. Acheson, M.K. Stachowiak, and E.M. Stricker Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical parkinsonism Arch Neurol 41 1984 856 861